ASX - Delayed Quote AUD

Althea Group Holdings Limited (AGH.AX)

Compare
0.0220
+0.0010
+(4.76%)
At close: 4:10:38 PM GMT+11
Loading Chart for AGH.AX
  • Previous Close 0.0210
  • Open 0.0210
  • Bid 0.0200 x --
  • Ask 0.0210 x --
  • Day's Range 0.0200 - 0.0220
  • 52 Week Range 0.0170 - 0.0540
  • Volume 147,797
  • Avg. Volume 622,947
  • Market Cap (intraday) 11.48M
  • Beta (5Y Monthly) 1.53
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

altheagroupholdings.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AGH.AX

View More

Performance Overview: AGH.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

AGH.AX
35.29%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

AGH.AX
35.29%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

AGH.AX
88.42%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

AGH.AX
92.14%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: AGH.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AGH.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    11.48M

  • Enterprise Value

    17.88M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.41

  • Price/Book (mrq)

    32.90

  • Enterprise Value/Revenue

    0.74

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -60.59%

  • Return on Assets (ttm)

    -18.54%

  • Return on Equity (ttm)

    -240.71%

  • Revenue (ttm)

    27.98M

  • Net Income Avi to Common (ttm)

    -18.68M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    563k

  • Total Debt/Equity (mrq)

    1,994.27%

  • Levered Free Cash Flow (ttm)

    -4M

Research Analysis: AGH.AX

View More

Company Insights: AGH.AX

Research Reports: AGH.AX

View More

People Also Watch